MedPath

Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-age

Completed
Conditions
Schizophrenia
Executive Function Disorders
Learning Disorders
Interventions
Diagnostic Test: Standardised semi-structured talk
Diagnostic Test: Autistic spectre disorder screening
Diagnostic Test: Anxiety measuring
Registration Number
NCT04280367
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The primary objective of the study aims to study transition toward schizophrenia in patients with learning disorders, and to compare the risk between patients with specific learning disorders, and patients with complexed learning disorders (by two types: patients with other neuro-developmental disorders including executive function disorders, and patients with anxiety).

Detailed Description

As secondary objectives, the study aims to:

* argue the clinical predicted markers (neuropsychological) transition toward psychosis.

* test the feasibility and the acceptability of a early diagnosis for a potential applicable guidance for different referent centers of learning in French territory.

* have a better classification of patients with learning disorders in order to target a prospective primary prevention of risk of psychosis via the questionnaires (AQ of Baron-Cohen: Autism-spectrum quotient auto-questionnaire; Inventory of Beck Anxiety Inventory, auto-questionnaire for panic disorder and general anxiety; Liebowitz Social Anxiety Scale).

* improve identification of the early signs and the early emerging psychological diseases intervention management (schizophrenia).

* Psychic disability: prevent and reduce non-seeking care and accompaniment situations, and risk of rupture of care.

* permitting better care of psychosocial rehabilitation with cognitive evaluation.

This study will be conducted in Centre de référence des troubles du langage et des apprentissages, Hôpital Raymond Poincaré, APHP, in France.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Patients born between 1990 and 2005, have been cared by Dr Schlumberger in 2014 in the center of language and learning disorders at Raymond Poincaré hospital;
  • With severe learning disorders: deficiency in school work, need at least one medical appointment and long-term rehabilitation in the center of language and learning disorders at Raymond Poincaré hospital;
  • Affiliated to a social protection schema;
  • Written informed consent signed.
Exclusion Criteria
  • Absence of learning disorder;
  • Intellectual deficiency;
  • Epilepsia;
  • Patients who will performed follow-up at Chartres city;
  • Patients under guardianship or curatorship;
  • Foreign patients under AME schema, a medical help from the state in France.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
neuro-developmental complexed groupAutistic spectre disorder screeningGroup of neuro-developmental complexe of learning
Comparator groupStandardised semi-structured talkSpecific learning disorders group
Comparator groupAnxiety measuringSpecific learning disorders group
Complexed with anxietyAnxiety measuringDisorders in learning with anxiety
neuro-developmental complexed groupStandardised semi-structured talkGroup of neuro-developmental complexe of learning
Comparator groupAutistic spectre disorder screeningSpecific learning disorders group
neuro-developmental complexed groupAnxiety measuringGroup of neuro-developmental complexe of learning
Complexed with anxietyStandardised semi-structured talkDisorders in learning with anxiety
Complexed with anxietyAutistic spectre disorder screeningDisorders in learning with anxiety
Primary Outcome Measures
NameTimeMethod
Semi-structured interviewAt baseline

Assessement with Comprehensive Assessment of At-Risk Mental States (CAARMS) during 6 to 90 minutes at the center of Raymond Poincaré hospital.

The unique collection during the interview, quotation of each patient will be given from the assessement.

There will be 4 groups by the results: CAARMS negative subjects, vulnerable subjects, attenuated psychosis subjects and subjects with brief and limited intermittent psychotic syndrome. The further statistic comparison will be done between the 3 last groups classified with results of CAARMS.

Secondary Outcome Measures
NameTimeMethod
Autistic screeningAt baseline

Autism-spectrum quotient (AQ) auto-questionnaire will be used to evaluate difficulty in social interaction.

Anxiety measuringAt baseline

An inventory for measuring clinical anxiety: Beck Anxiety Inventory

Social interaction difficulty evaluationAt baseline

Liebowitz Social Anxiety Scale as questionnaire

Trial Locations

Locations (1)

Centre de référence des troubles du langage et des apprentissages, Hôpital Raymond Poincaré

🇫🇷

Garches, France

© Copyright 2025. All Rights Reserved by MedPath